AWI vs TTEK

AWI's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite strong profitability metrics like a 38.03% ROE and solid earnings growth, elevated valuation multiples and weak insider sentiment weigh on the outlook. The stock trades above its Graham Number of $56.59 and near its intrinsic value estimate of $184.15, suggesting limited margin of safety. Analysts maintain a 'buy' recommendation with a $211.10 target, implying upside, but recent insider selling and deteriorating short-term earnings momentum raise caution.

TTEK demonstrates stable financial health with a Piotroski F-Score of 6/9 and a strong ROE of 19.92%. While the company possesses an exceptional track record of beating earnings estimates over 25 consecutive quarters, current revenue growth is a significant concern at -13.40% YoY. The stock trades at a steep premium to its Graham Number ($14.55) but remains below its growth-based intrinsic value ($39.23). Bearish technical trends and insider selling currently offset the positive analyst consensus and fundamental stability.